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Objective: To investigate usefulness of osteochondral grafting from the costo-osteochondral junction as
a repair technique for articular cartilage defects histologic and biochemical analysis of grafted cartilage in
rabbit knees was evaluated up to 48 weeks after transplantation.
Methods: Twenty New Zealand White rabbits were used. A costal osteochondral plug was harvested from
a middle rib. After trimming, it was transplanted into a cylindrical osteochondral 2.5 mm diameter and
5 mm deep defect created in the knee. The animals were sacriﬁced at 6, 12, 24, and 48 weeks after
transplantation. Defect sites were inspected macroscopically, and then by light microscopy. Samples
were evaluated for cell viability using a ﬂuorescent in situ double-staining protocol with confocal laser
microscopic analysis. Samples were also processed to assess type I & II collagen and aggrecan mRNA
expression using reverse transcription-polymerase chain reaction (RT-PCR).
Results: Histologically, bone union was achieved in all plugs. Confocal microscopic analysis revealed
chondrocyte viability in the 48-week grafts; the distribution of chondrocytes was similar to surrounding
articular cartilage. The expression of type II collagen and aggrecan mRNA in the grafted cartilage was
consistent with normal articular cartilage and normal costal cartilage. These results were observed over 6e
48 weeks.
Conclusions: Our study revealed that chondrocytes in the grafted cartilage were viable at least up to
48 weeks and that mRNA expression of type II collagen and aggrecan was also similar to that of normal
articular cartilage. These results suggest that costal osteochondral grafting can be a useful alternative in
the treatment of osteochondral defects.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Treatment of articular cartilage injuries remains an important,
yet unresolved, issue in orthopedics. Drilling of the subchondral
bone is expected to provide only a ﬁbrocartilage layer and is an
imperfect choice for repair of damaged articular hyaline cartilage.
Osteochondral grafting has been performed clinically as a reli-
able method of treating articular cartilage injuries, with newer
techniques using tissue engineering with or without gene-
enhancement having been recently introduced1e5. To date, there
have been many reports on osteochondral grafts, and it has beento: K. Sato, Department of
niversity, 35 Shinanomachi,
-3812; Fax: 81-3-3353-6597.
s Research Society International. Pconﬁrmed in animal experiments that chondrocytes can maintain
their biochemical and biomechanical characteristics after trans-
plantation6e26. Satisfactory clinical results have also been observed
in short-term follow-up studies. It is generally agreed that this
technique is useful as a one-stage repair technique for articular
cartilage defects caused by trauma6,8,10,12,13,15,16,21e26.
Allografts or autografts harvested from non-weight-bearing
areas of the knee joints have been used6e26. Munro et al.27,
however, reported viability of the osteochondral grafts harvested
from the costo-osteochondral junction used in the temporoman-
dibular joint in 1989. Using this same technique Hasegawa et al.28
and Sandow29 treated ﬁnger joint injuries and deﬁciencies of the
proximal pole of the scaphoid from fracture or osteonecrosis,
respectively, and observed satisfactory therapeutic outcomes.
Whenwe utilized this technique to repair articular cartilage defects
or disorders in the upper extremity, including 44 elbows, one wrist,ublished by Elsevier Ltd. All rights reserved.
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Recently, it was reported that costal cartilage shows phenotypic
similarities to articular cartilage35, and that costal cartilage may
therefore be useful as the donor for the treatment of articular
cartilage defects. There have been few previous studies of costal
osteochondral grafts36,37.
In this study, histologic and biochemical analysis of grafted
cartilage in rabbit knees was evaluated up to 48 weeks after
transplantation in order to evaluate the usefulness of costal
osteochondral graft to assist restoration of congruent joint surfaces.Materials and methods
Operative procedure
Twenty skeletally mature (>12 months) female New Zealand
white rabbits (3.4e5.1 kg) were used. They were housed in the
Animal Care Facility of University at Buffalo, State University of New
York, in full compliance with Institutional Animal Care and Use
Committee guidelines. They were pre-anesthetized with ketamine
HCl and xylazine, intubated and administered Isoﬂurane gas.
Surgery was performed bilaterally using sterile technique. The skin
was shaved, washed with 70% alcohol, and disinfected with
povidone-iodine. The chest skinwas shaved and disinfected as well.
Through the medial parapatellar approach, the knee capsule was
incised, and the patella was dislocated laterally to expose the
patellar groove of the femur. An osteochondral 2.5 mm diameter
and 5 mm deep defect was drilled off along the midline of the
patellar groove using a drill bit. After making osteochondral defects
in the both knees a costal osteochondral autograft was harvested
from the costo-osteochondral junction of a rightmiddle rib through
a transverse sub-mammary incision. Costal cartilage was excised
using scissors, being careful to avoid perforating into the thoracic
cavity. Harvested graft was trimmed to ﬁt the defect using rongeur
forceps for bone and scalpel for cartilage, and then press-ﬁt into the
previously described defect in the right knee so that it would not
protrude from the adjacent native cartilage [Fig. 1(AeC)]. As
a control a matching defect was made in the contralateral knee and
kept untreated in the left knee.
After transplantation each joint was irrigated with saline to
remove any loose fragments. The patella was repositioned and the
medial aspect of the capsule was repaired with a 4-0 absorbable
suture. The subcutaneous tissues and skin were closed with non-
absorbable 4-0 nylon suture in each knee. No casts were applied.
The animals were allowed free access to diet in their cages soon
after surgery.Fig. 1. (A) Harvested costal osteochondral transit site. The arrow shows costal
cartilage. (B) Costal cartilage (arrow) was shaped to ﬁt the defect with a scalpel and
osseous portion (rib) was trimmed with bone rongeur forceps. (C) The costal
osteochondral plug press-ﬁtted into the femoral defect.Macroscopic and histological evaluation
The animals were sacriﬁced by an overdose of sodium pento-
barbital at 6, 12, 24, and 48 weeks (n¼ 5 in each group) after
transplantation. Defect sites were inspected macroscopically and
then by light microscopy. The transplanted graft with an approxi-
mately 5 mm margin was removed from the knee using a chisel.
The sample was microscopically cut sagittally into thirds (i.e., three
sagittal parallel slices). The cartilage area was cut carefully and the
osseous part was cut by strong power in one stroke with a razor
blade. This procedure was carried out based on results that thirty
samples were preliminary cut into three sagittal parallel slices at
the success rate of 100%. One-third was ﬁxed in 10% buffered
formalin phosphate, decalciﬁed in 5% formic acid, embedded in
parafﬁn, and then sliced into 5-mm thick sections. Hematoxylin and
eosin, and Safranin-O stains were made in sections from each
defect (Fig. 2).Histological grading score for assessment of repaired cartilage
Matrix staining in the grafted costal cartilage (above and below
the tidemark) and the control was evaluated blindly by two inde-
pendent investigators (KS and TN). Matrix staining, or the degree of
metachromatic stainingwith Safranin-O,was graded from0 (absence
of staining) to 4 points (for tissue that had normal/slight reduction in
stain compared with adjacent, uninjured cartilage) (Table I). This
grading system is in opposite scale to theMankin scoring system38,39.
Fig. 2. Illustration of the experimental design.
Table II
PCR primer sequences and sources used in this study
Gene Base
pairs
Primer sequences Primer source
Collagen 312 50-GATGGCCTGAAGCTCAA-30 T Majima et al. (41)
0 0
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Another one-third of each specimen was evaluated for cell
viability using a ﬂuorescent in situ double-stain protocol followed
by confocal laser microscopic analysis (Fig. 2). These specimens
were cut into approximately 1.0-mm thick sagittal sections and
incubated for 30 min at room temperature in a 10 ml phosphate
buffered saline of 5 mM calcein AM and 5 mM ethidium homodimer
(Molecular Probes, Eugene, OR, USA). This technique is based on the
knowledge that viable and non-viable cells differ in their ability to
exclude hydrophobic ﬂuorescent dyes such as ethidium homo-
dimer. The cell membranes of damaged, dead, or dying cells are
penetrated by ethidium homodimer to stain their nuclei red. Viable
cells with intact plasma membranes and active cytoplasm metab-
olize calcein and show green ﬂuorescence40. A confocal laser
microscope (MRC-1024, Bio-Rad, Hemel Hempsted/Cambridge,
England) equipped with a krypton/argon laser and ﬁlter systems of
HQ598/40 and 522DF32 was used to show ﬂuorescence.
To calculate viable cell density three coordinates were selected
randomly within each 1-mm thick section in both the costal osteo-
chondral graft and the control groups. At each of the three coordi-
nates, optical sections were obtained in 5-mm increments, within
a volume of approximately 150 mm 150 mm 30 mm. The total
number of live cells per area was counted using ImageJ (National
Institutes of Health, Bethesda, MD). Data were expressed as relative
cell density by comparing the cell density values (cells/mm2) in
question with values in adjacent articular cartilage.
Reverse transcription-polymerase chain reaction (RT-PCR)
(1) RNA extraction and cDNA preparation
Remaining one-third of each specimen was processed to assess
type I and II collagen and aggrecan mRNA expression in the
grafted cartilage or regenerated tissue using RT-PCR (Fig. 2).
Isolation of total RNA was done using the Total RNA Isolation Kit
from the Biomedical Research Service Center of the University at
Buffalo, State University of New York. Samples were placed in
0.5 ml of RNA Extract Solution and homogenized. Supernatant ofTable I
Matrix staining score
Normal/slight reduction 4
Staining reduced in radial layer 3
Reduced in interterritorial matrix 2
Only present in pericellular matrix 1
Absence 0homogenate was transferred to a 2-ml microtube, and extracted
with 0.5 ml of RNA phenol. The tube was centrifuged for 10 min
and the upper aqueous phase was transferred to another 2-ml
microtube. RNA was precipitated by adding an equal volume of
ice-cold isopropanol and left at 20C for 30 min or longer. The
tube was centrifuged for 5 min and supernatant was completely
aspirated. The RNA pellet was vortexed in 0.5 ml of 70% ethanol
for 30 s and was centrifuged for 2 min. Ethanol was completely
aspirated and samples were air-dried. RNA was then dissolved in
40e200 ml of DEPC-treated water. The concentration of total RNA
was quantiﬁed by spectrophotometry, measuring OD260. Total
RNA concentration was adjusted to 80 ng/ml for all samples for
reverse transcription using the random-hexamer priming
method. ThemRNAwas converted to single-stranded cDNA using
the cDNA Synthesis Kit from the Biomedical Research Service
Center of the University at Buffalo, State University of New York.
Brieﬂy, the cDNA synthesis reaction mixture contained 800 ng
heat-denatured RNA, 8 ml Reverse Transcription Mix, 40 units
RNase inhibitor, and 20 units M-MuLV reverse transcriptase.
Reaction was allowed to proceed at 37C for 60 min, and cDNA
products were stored at 20C prior to PCR analysis. For analysis
of aggrecan expression, synthesis of aggrecan cDNA was primed
with the speciﬁc aggrecan 30 primers (Table II).(2) DNA ampliﬁcation
Semiquantitative PCR was performed using the DNA Ampliﬁca-
tion Kit from the Biomedical Research Service Center of the
University at Buffalo, State University of New York. The target
sequences in the reverse-transcribed cDNA samples were
ampliﬁed by PCR, using sequence-speciﬁc oligonucleotide
primers designed to yield approximately 200e300 bp sequencesⅠ (a1) 5 -GGTTTGTTGAAGAGGCTG-3
Collagen Ⅱ 366 50-GCACCCATGGACATTGGAGGG-30 T Majima et al. (41)
50-GACACGGAGTAGCACCATTCG-30
Aggrecan 313 50-GAGGAGATGGAGGGTGAGGTCTT-30 EK Bayne et al./
Genbank accession
number L38480
50-CTTCGCCTGTGTAGCAGATG-30
GAPDH 293 50-TCACCATCTTCCAGGAGCGA-30 SE Applequist
et al./Genbank
accession number
L23961
50-CACAATGCCGAAGTGGTCGT-30
Fig. 3. Osteochondral defects after surgery. (A) Costal osteochondral graft at 6 weeks after surgery. (B) Control at 6 weeks after surgery. The defect was ﬁlled with semitransparent
tissue but it was still in a concave shape. (C) Costal osteochondral graft at 12 weeks after surgery. The graft had white and shiny surface but the margin between the graft and
surrounding articular cartilage was still distinguishable. (D) Control at 12 weeks after surgery. The surface of the defect was mostly ﬂat and looked white and shiny. (E) Costal
osteochondral graft at 24 weeks after surgery. Although the margin was still distinguishable, the surface of the graft looked like normal articular cartilage. (F) Control at 24 weeks
after surgery. The surface of the defect was rough and irregular. (G) Costal osteochondral graft at 48 weeks after surgery. The surface of the graft was still white and shiny. There was
no sign of degenerative change. (H) Control at 48 weeks after surgery. The defect had white but irregular surface.
K. Sato et al. / Osteoarthritis and Cartilage 20 (2012) 172e183 175spanning exons within aggrecan and both type I and II collagen
genes37 (Table I). PCR was carried out in 20 ml volume containing
2 ml cDNA (4 ml for aggrecan), 20 ng 50 and 30 primers (Table I), 6 ml
PCR Mix, and 2.5 units Taq Polymerase. The standard 30-cyclePCR protocol was: denaturation at 94C for 30 s, annealing at
55C for 30 s, and extension at 72C for 90 s, and the product was
allowed a ﬁnal 5-min time delay at 72C. The PCR products were
analyzed by 1% agarose gel electrophoresis.
Fig. 4. Histological ﬁndings of osteochondral defect at 6 (AeD), 12 (EeH), 24 (IeL) and 48 (MeP) weeks after surgery. (A) Histology of grafted costal cartilage at 6 weeks. Bone union
was achieved at the subchondral bone level and chondrocytes in the graft looked viable in costal osteochondral graft (Hematoxylin-eosin; magniﬁcation 40). (B) Histology of
grafted costal cartilage at 6 weeks. The matrix in the grafted costal cartilage was stained red which suggests the existence of glycosaminoglycans (Safranin-O; magniﬁcation 40).
(C) Histology of untreated control at 6 weeks. The repair tissue was more cellular than adjacent articular cartilage and it possessed a population of smaller-sized cell (Hematoxylin-
eosin; magniﬁcation 40). (D) Histology of untreated control at 6 weeks. The matrix of regenerated cartilage-like tissue was stained red (Safranin-O; magniﬁcation 40). (E)
Histology of grafted costal cartilage at 12 weeks. Chondrocytes in the graft looked healthy but the gap between the cartilage layer of the graft and the surrounding articular cartilage
had continuity to ﬁbrocartilage-like tissue, but not hyaline cartilage (Hematoxylin-eosin; magniﬁcation 40). (F) Histology of grafted costal cartilage at 12 weeks. Although the
matrix in the grafted cartilage was stained red at high levels with Safranin-O, the gap between the cartilage layer of the graft and the surrounding articular cartilage was not stained
well (Safranin-O; magniﬁcation 40). (G) Histology of untreated control at 12 weeks. The surface of the regenerated cartilage was irregular (Hematoxylin-eosin; magniﬁcation 40).
(H) Histology of untreated control at 12 weeks. Regenerated cartilage-like tissue was stained red but not so intense (Safranin-O; magniﬁcation 40). (I) Histology of grafted costal
cartilage at 24 weeks. Chondrocytes in the grafted cartilage looked healthy (Hematoxylin-eosin; magniﬁcation 40). (J) Histology of grafted costal cartilage at 24 weeks. The gap
between the cartilage layer of the graft and the surrounding articular cartilage was slightly stained red (Safranin-O; magniﬁcation 40). (K) Histology of untreated control at
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All numerical results were expressed as a mean 95% conﬁ-
dence interval (95% CI). Matrix staining scores of the grafted
cartilage above and below the tidemark groups and the control
group were statistically compared at each period using one-way
analysis of variance (ANOVA) with Ranks nonparametric Tukey
post-hoc test. Differences of periods (6, 12, 24, and 48 weeks) were
also determined by the same test. Simultaneously, relative density
of live cell in the grafted costal cartilage was statistically compared
to that in the control. P value of less than 0.05 was considered
statistical signiﬁcance. Sigma stat statistical package was used
(version 3.1, Systat Software Inc., Richmond, CA).Results
Macroscopic ﬁndings
Macroscopic examination of operated knees revealed no
evidence of infection.
At 6 weeks, the gross appearance of the grafts was white,
smooth, and glistening, and they looked like normal articular
cartilage. The margins of the grafts were clearly recognizable
grossly and indicated the lack of continuity between the graft and
surrounding articular cartilage. In the control group the defect
surface was irregular ﬁlled with white, semitransparent tissue
[Fig. 3(A,B)].
At 12 weeks, the surface of the graft was glossy-white, like
normal articular cartilage, and the gap between the graft and the
host was ﬁlled with ﬁbrous tissue. The margin of the graft was still
distinguishable. In the control group the defects had mostly ﬂat,
white, and shiny surface at 12 weeks [Fig. 3(C,D)].
At 24 and 48 weeks, the ﬁndings of the grafted cartilage were
almost the same as those at 12 weeks and there was no sign of
degenerative change. In contrast, the surface of the regenerated
cartilage in the control group became rough, and the previously
noted glossy white color was diminished at 24 weeks, with these
changes more obvious at 48 weeks [Fig. 3(EeH)].Histological ﬁndings
At 6 weeks, bone union was achieved histologically at the
subchondral level in all costal osteochondral grafts. Chondrocytes
were seen in the lacunae and there were no evidence of acute
inﬂammation nor necrosis. The cartilage matrix was clearly stained
by Safranin-O. Microscopic examination revealed a clear gap
between the cartilage layer of the graft and the surrounding
cartilage in most cases. In the control group though there were
more cells in irregular arrangement relative to surrounding artic-
ular cartilage. A nearly-normal cartilage-like tissue was formed and
staining of thematrix by Safranin-Owas observed in the defect that
suggests synthesis of a cartilage extracellular matrix [Fig. 4(AeD)].
At 12 weeks, chondrocytes in the grafted cartilage looked
healthy and there were no obvious changes. The gap between the
cartilage layer of the graft and the surrounding cartilage had
continuity to ﬁbrocartilage-like tissue, but not to hyaline cartilage.
The gap either was not stained or slightly stained by Safranin-O. In24 weeks. Regenerated cartilage-like tissue showed ﬁbrillation (Hematoxylin-eosin; magn
Safranin-O staining of the matrix was diminished compared with the adjacent cartilage (Safr
was no evidence of degenerative changes (Hematoxylin-eosin; magniﬁcation 40). (N) Hi
compared with 24 weeks (Safranin-O; magniﬁcation 40). (O) Histology of untreated co
(Hematoxylin-eosin; magniﬁcation 40). (P) Histology of untreated control at 48 weeks. The
O; magniﬁcation 40). Bars¼ 500 mm.the control group though there were more cells and their
arrangement was more irregular than in surrounding articular
cartilage, a nearly-normal cartilage-like tissue was formed and
slight staining of the matrix by Safranin-O was observed in the
defect [Fig. 4(EeH)].
At 24 weeks, clusters of chondrocytes formed at the junction
between the graft and the host. The gapwas stainedwith Safranin-O,
but its intensity was weaker than grafted cartilage and surrounding
cartilage. Although the transplantedgraftwas thicker than that of the
host articular cartilage fromthebeginning, it didnot change at all and
stained well by Safranin-O. This ﬁnding might suggest the presence
of equivalent glycosaminoglycans content in the grafted cartilage as
in surrounding articular cartilage. In contrast, in the control group
surface ﬁbrillation was seen and the intensity of the Safranin-O
staining of the cartilage matrix was diminished compared with the
adjacent cartilage at 24 weeks [Fig. 4(IeL)].
At 48 weeks, grafted cartilage remained almost the same as
24 weeks. There were no evidence of degenerative changes and the
intensity of the grafted cartilage by Safranin-O was similar to the
surrounding articular cartilage, while the incorporation of the
osteochondral graft to the native adjacent cartilage was still
observed. In the control group, degenerative changes became
remarkable. Fissuring was seen in the superﬁcial layers of the
regenerated cartilage and the cartilage layer became thinner
[Fig. 4(MeP)].
For the purpose of acquiring stable bonding we evaluated the
cartilage layer of the graft and the surrounding articular cartilage
after treatment with chondroitinase ABC and various concentra-
tions of basic ﬁbroblast growth factor (b-FGF) in another project
(unpublished results). We hypothesized that treatment of the edges
of the exposed cartilage in the graft and surrounding articular
surface with chondroitinase ABC before transplantation might
enhance cellular adhesion, and insertion of a collagen sponge with
b-FGF might enhance cartilage regeneration at the gap. But in all
our trials, we could not achieve such integration of the borders
(unpublished results).Histological grading score for assessment of repaired cartilage
The matrix staining scores of the grafted cartilage above/below
the tidemark group sections 6, 12, 24, and 48 weeks after the
surgery were 4.00 (95% CI: [4.00e4.00], n¼ 5)/4.00 (95% CI:
[4.00e4.00], n¼ 5) (above/below the tidemark), 4.00 (95% CI:
[4.00e4.00], n¼ 5)/4.00 (95% CI: [4.00e4.00], n¼ 5), 3.80 (95%
CI: [3.24e4.36], n¼ 5)/3.50 (95% CI: [2.88e4.12], n¼ 5), and 3.80
(95% CI: [3.24e4.36], n¼ 5)/3.20 (95% CI: [2.64e3.76], n¼ 5),
respectively (Table III, Fig. 5). There was no signiﬁcant difference
between above the tidemark group and below the tidemark group
at the corresponding week, respectively, while the score of the
grafted cartilage below the tidemark group at 48 weeks was
signiﬁcantly lower than that from 6 weeks (P ¼ 0.013). The matrix
staining scores of the control group sections at 6, 12, 24, and
48 weeks after the surgery were 1.50 (95% CI: [0.88e2.12], n¼ 5),
1.30 (95% CI: [0.75e1.86], n¼ 5), 0.20 (95% CI: [0e0.76], n¼ 5), and
0.10 (95% CI: [0e0.38], n¼ 5), respectively, and signiﬁcantly lower
24 and 48 weeks after the surgery than for that of 6 weeks
(P ¼ 0.016, 0.001).iﬁcation 40). (L) Histology of untreated control at 24 weeks. The intensity of the
anin-O; magniﬁcation 40). (M) Histology of grafted costal cartilage at 48 weeks. There
stology of grafted costal cartilage at 48 weeks. There were no remarkable differences
ntrol at 48 weeks. Regenerated cartilage-like tissue showed remarkable ﬁbrillation
intensity of the Safranin-O staining of the matrix was completely diminished (Safranin-
Fig. 4. (continued).
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Confocal microscopic analysis revealed chondrocyte viability in
the grafted cartilage and few non-viable cells in any specimens.Multiple green ﬂuorescing living cells were seen in the graft. The
distribution of chondrocytes in the graft was essentially uniform as
is seen in normal costal cartilage and it was grossly similar to
surrounding articular cartilage. There were few viable cells at the
Table III
Matrix staining score
6 weeks 12 weeks 24 weeks 48 weeks
Matrix staining
score
No. of
sections
Matrix staining
score
No. of
sections
Matrix staining
score
No. of
sections
Matrix staining
score
No. of
sections
Grafted cartilage/
above the tidemark
4.00 0.00 5 4.00 0.00 5 3.80 0.88 5 3.80 0.88 5
Grafted cartilage/
below the tidemark
4.00 0.00 5 4.00 0.00 5 3.50 0.98 5 3.20 0.88* 5
Control 1.50 0.98 5 1.30 0.88 5 0.20 0.88* 5 0.10 044* 5
* P< 0.05 vs 6 weeks in each group.
K. Sato et al. / Osteoarthritis and Cartilage 20 (2012) 172e183 179junction in the cartilage layer, suggesting lack of integration
between the grafted cartilage and surrounding articular cartilage,
and consistent with the histological results. These ﬁndings
remained the same throughout all times and specimens to
48 weeks [Fig. 6(A)].
The distribution of the live cells in the grafted cartilage was
almost uniform over 6e48 weeks and its density was consistent
with that of adjacent articular cartilage. The “repair tissue” in the
control group was found to be more cellular than the adjacent
articular cartilage and possessed a smaller-sized population of cells.
This result also remained the same over 6e48 weeks [Fig. 6(B)]. The
relative cell density of the costal osteochondral graft at 6, 12, 24,
and 48 weeks after the surgery were 1.09 (95% CI: [0.81e1.37],
n¼ 15), 1.04 (95% CI: [0.79e1.29], n¼ 15), 1.08 (95% CI: [0.82e1.34],
n¼ 15), and 1.08 (95% CI: [0.82e1.34], n¼ 15) respectively, while
those of the control were 1.79 (95% CI: [1.38e2.20], n¼ 15), 1.70
(95% CI: [1.42e1.98], n¼ 15), 1.74 (95% CI: [1.39e2.09], n¼ 15), and
1.67 (95% CI: [1.33e2.01], n¼ 15). There was statistical signiﬁcance
on themean value of live cells density between the grafted cartilage
and the control throughout the experience (P< 0.001 at 6 weeks,
P¼ 0.002 at 12 weeks, 0.001 at 24 weeks, and 0.004 at 48 weeks).RT-PCR
Wet weights of cartilage samples were 2.7e12.8 mg, and total
RNA yields were 3.2e11.3 mg. The mRNA for glyceraldehydes-Fig. 5. Matrix staining score. The score of the grafted cartilage below the tidemark group a
control group sections 24 and 48 weeks after the surgery were signiﬁcantly lower than that
6 weeks in each group.3-phosphate dehydrogenase was expressed at high levels in all
samples. The expression of type I collagen, type II collagen and
aggrecan mRNA in costal osteochondral graft and the control
analyzed by RT-PCR was shown in Fig. 7. The expression of type I
collagen mRNA in normal articular cartilage and normal coastal
cartilage was absent. The expression of type II collagen mRNA and
aggrecan mRNA in normal costal cartilage were as strong as in
normal articular cartilage.
The expression of type I collagen mRNA in the grafted costal
cartilage was absent at all times examined, as opposed the
expression of type I collagen mRNA in the control group was strong
after peaking in 12 weeks.
The expression of type II collagen mRNA in the grafted costal
cartilage was strong and constant at all times examined, while its
level was weak or absent in the control group.
The expression of aggrecan mRNA in the grafted costal cartilage
was as strong as in normal costal cartilage and maintained
a constant value until 48 weeks. While the expression of aggrecan
mRNA in the control was as same as in normal articular cartilage at
6 weeks, it decreased at 12, 24, and 48 weeks with the time
passage. A decrease of almost 50% was observed at 48 weeks.Discussion
The histological ﬁndings in this study demonstrate that an
osteochondral defect in the rabbit model can be successfullyt 48 weeks was signiﬁcantly lower than that at 6 weeks (P ¼ 0.013). The scores of the
of 6 weeks (P ¼ 0.016, 0.001). Data expressed as mean with 95% CIs (n¼ 5). *P < 0.05 vs
Fig. 6. (A) Confocal laser microscopic ﬁndings at 48 weeks after surgery. Multiple green ﬂuorescing living cells were seen in the graft as well as surrounding articular cartilage.
(B) Relative cell density in the grafted costal cartilage and in the control. Data expressed as meanwith 95% CIs (n¼ 15: three coordinates from one animal, ﬁve animals in each group).
K. Sato et al. / Osteoarthritis and Cartilage 20 (2012) 172e183180reconstructed using costal osteochondral graft. No obvious ﬁbrosis
or necrosis was observed up to 48 weeks after transplantation in
animals bearing unrestricted weight at full activity. These results
are compatible with the results of Hurtig MB et al.18 who reported
that in an ovine model the transplanted standard autografts har-
vested from a knee joint were not signiﬁcantly different even at
12 months postoperatively when compared to the surrounding
cartilage. However, incomplete integration with the adjacent,
native articular cartilage was observed in four samples out of ﬁve.
The junction between the cartilage layer of graft and the
surrounding articular cartilage was thought to be ﬁlled withFig. 7. Expression of type I collagen, type II collagen and aggrecan mRNAwere assessed by R
the control. Type I collagen was not detected in costal osteochondral graft. The band for ag
(C) normal articular cartilage, (D) normal costal cartilage.ﬁbrocartilage. Our results were consistent with many previous
publications on standard osteochondral grafts6e26. Other investi-
gators have reported that the lack of integration of repair tissue
with adjacent cartilage is unrelated to the method of treatment or
the size of the defect42,43 and our results were consistent with that.
In our animals, even the costal osteochondral grafts which had
been press-ﬁt into the defects, bonding was achieved with ﬁbrous
tissue or ﬁbrocartilage, not from hyaline cartilage.
Integration at the cartilage junction is a difﬁcult problem
because chondrocytes in the grafted cartilage and the surrounding
cartilage are not involved in “repair” and they do not migrate intoT-PCR. The band for type II collagen was more intense in costal osteochondral graft than
grecan was more intense than the control. (A) costal osteochondral graft, (B) control,
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continuity and bonding between the graft and the host not only at
subchondral bone level, but also between the cartilage layer of graft
and the surrounding articular cartilage is thought to be important
in obtaining satisfactory long-term outcomes. Therefore, a method
for providing a stronger bond between the graft cartilage and the
surrounding normal articular cartilage still needs to be developed.
We hypothesized that treatment of the edges of the exposed
cartilage with chondroitinase ABC and b-FGF might enhance
cartilage regeneration at the gap, an hypothesis that was based on
the report of Hunzinker et al.38 where they observed migration of
mesenchymal cells from the synovial membrane to the defect in
a partial-thickness defect model with New Zealand white rabbits.
In their study, proteoglycanwas removed from the cartilage surface
by administration of chondroitinase ABC, and a transforming
growth factor-b1 (TGF-b1) or b-FGF was given. While we could not
obtain desired integration at the cartilage layer in all our trial
(unpublished results), Olivous-Meza et al.44 recently reported that
in situ pretreatment of periosteum with TGF-b1 improved osteo-
chondral tissue regeneration in rabbit. This report suggests that
improvement in structural integrity could potentially be obtained
under at least optimal condition. Further experimental investiga-
tion of the functional and biologic integration of graft to adjacent
articular cartilage is necessary to verify the long-term effects of
osteochondral transplantation.
Another important factor that affects the fate of the grafted
cartilage is the presence or absence of the structural fragility of the
graft due to differences between its matrix components and those
of the surrounding normal articular cartilage. In our study themean
relative expressions of type II collagen and aggrecan, a major
proteoglycan in the articular cartilage, in the grafted costal cartilage
were constant over 6e48 weeks and they were quite similar to
those of normal articular cartilage and normal costal cartilage.
These results suggest the biochemical properties of these major
components in the graft maintained at least up to 48 weeks. While
type I collagen was not detected in the grafted costal cartilage, it
was abundant in the control group, which suggests that the
regenerating matrix in the control group differs from those of
normal articular cartilage in its biochemical components and ratio,
and this regenerating cartilage is thought to degenerate when
mechanical stress is imposed. As described previously, it did occur
at 24e48 weeks in the control group. Our results in the control
group were consistent with the previous report of Shapiro43.
The costal osteochondral graft is typically different from the
standard osteochondral graft in the thickness of the cartilage layer.
The thickness of the costal cartilage was determined when the
surgeon manually trim the harvested graft in our study. Although
the surgeon tried to trim it as thin as possible, the thickness
becomes 1e2 mm according to an individual sample, and it is 2e3
times thicker than normal articular cartilage in the recipient knee.
Thus, the cartilage layer of the costal osteochondral graft is thicker
than normal articular cartilage from the beginning of trans-
plantation. The graft was press-ﬁt manually into the defect and it
was checked by ﬁngertip palpation at to whether the graft
protruded from the adjacent native cartilage.We ﬁrmly believe that
protrusion of the graft was<0.1 mm and there would have been no
mechanical irritation against the opposite articular surface during
loaded motion. As the basis of this belief, there was no scraping or
abrasion on the opposing articular surface at the time of harvesting.
Histological ﬁndings revealed that the cartilage matrix in the
graft was clearly stained by Safranin-O even at 48 weeks while the
intensity of the staining was weak and the matrix staining score
was signiﬁcantly low below the tidemark at 48 weeks compared to
that at 6 weeks. It may suggest that the costal cartilage remained
healthy until 48 weeks after transplantation though hypertrophy tobone started below the tidemark. A study for longer-term group
might have been necessary to assess the hypertrophy of the costal
cartilage to bone below the tidemark.
In these knees, the viability of chondrocytes in the grafted costal
cartilage was conﬁrmed up to 48 weeks using a ﬂuorescent in situ
double-staining protocol with confocal laser microscopic analysis.
The distribution of viable cellswas grossly constantover 6e48 weeks
and itwas similar to that of the surrounding articular cartilage.While
this method did not clarify the cell types in the graft, no obvious
migration of other cells was seen in histological samples. It can be
concluded that the chondrocytes in the grafted cartilage survived at
least up to 48 weeks and their distribution did not changewith time.
Although bonding between the cartilage layer of graft and
surrounding articular cartilage was biologically insufﬁcient, the
histological ﬁndings showed nearly perfect restoration of articular
cartilage defect, and the ﬂuorescent in situ double-staining protocol
with confocal laser microscopic analysis revealed viability of
chondrocytes in the grafted costal cartilage up to 48 weeks. In
addition, RT-PCR analysis conﬁrmed that mRNA expression of type
II collagen and aggrecan in the graft was maintained at least up to
48 weeks and they were quite similar to normal articular cartilage
and normal costal cartilage. To our knowledge, this is the ﬁrst time
that costal osteochondral graft was evaluated histologically and
biochemically in this scenario.
Although recent techniques using tissue engineering with or
without gene-enhancement are theoretically promising for the
restoration of damaged articular cartilage, they are, at this time,
imperfect1e5; and osteochondral grafting is still one of the most
reliable clinical methods available to repair cartilage disorders or
defects5. Our results in this experimental model suggest to us that
costal osteochondral grafting is a useful alternative in the treat-
ment of osteochondral defects, especially in relatively smaller
joints such as elbows, wrists, and ﬁngers.
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